Vanguard Personalized Indexing Management, LLC Prelude Therapeutics Inc Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 11,925 shares of PRLD stock, worth $10,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,925Holding current value
$10,374% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRLD
# of Institutions
59Shares Held
30.4MCall Options Held
6.4KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$9.49 Million0.38% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$8.81 Million0.14% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$929,9560.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.03MShares$895,4030.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$879,0410.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $31.6M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...